@phdthesis{Popp2021, author = {Popp, Christina}, title = {Evolution of antifungal drug resistance of the human-pathogenic fungus \(Candida\) \(albicans\)}, doi = {10.25972/OPUS-24351}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-243515}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2021}, abstract = {Infections with the opportunistic yeast Candida albicans are frequently treated with the first-line drug fluconazole, which inhibits ergosterol biosynthesis. An alarming problem in clinics is the development of resistances against this azole, especially during long-term treatment of patients. Well-known resistance mechanisms include mutations in the zinc cluster transcription factors (ZnTFs) Mrr1 and Tac1, which cause an overexpression of efflux pump genes, and Upc2, which results in an overexpression of the drug target. C. albicans strains with such gain-of-function mutations (GOF) have an increased drug resistance conferring a selective advantage in the presence of the drug. It was previously shown that this advantage comes with a fitness defect in the absence of the drug. This was observed in different conditions and is presumably caused by a deregulated gene expression. One aim of the present study was to examine whether C. albicans can overcome the costs of drug resistance by further evolution. Therefore, the relative fitness of clinical isolates with one or a combination of different resistance mutations in Mrr1, Tac1 and/or Upc2 was analyzed in competition with the matched fluconazole-susceptible partner. Most fluconazole-resistant isolates had a decreased fitness in competition with their susceptible partner in vitro in rich medium. In contrast, three fluconazole-resistant strains with Mrr1 resistance mutations did not show a fitness defect in competition with their susceptible partner. In addition, the fitness of four selected clinical isolate pairs was examined in vivo in mouse models of gastrointestinal colonization (GI) and disseminated infection (IV). In the GI model all four fluconazole-resistant strains were outcompeted by their respective susceptible partner. In contrast, in the IV model only one out of four fluconazole-resistant isolates did show a slight fitness defect in competition with its susceptible partner during infection of the kidneys. It can be stated, that in the present work the in vitro fitness did not reflect the in vivo fitness and that the overall fitness was dependent on the tested conditions. In conclusion, C. albicans cannot easily overcome the costs of drug resistance caused by a deregulated gene expression. In addition to GOFs in Mrr1, Tac1 and Upc2, resistance mutations in the drug target Erg11 are a further key fluconazole resistance mechanism of C. albicans. Clinical isolates often harbor several resistance mechanisms, as the fluconazole resistance level is further increased in strains with a combination of different resistance mutations. In this regard, the question arises of how strains with multiple resistance mechanisms evolve. One possibility is that strains acquire mutations successively. In the present study it was examined whether highly drug-resistant C. albicans strains with multiple resistance mechanisms can evolve by parasexual recombination as another possibility. In a clonal population, cells with individually acquired resistance mutations could combine these advantageous traits by mating. Thereupon selection could act on the mating progeny resulting in even better adapted derivatives. Therefore, strains heterozygous for a resistance mutation and the mating type locus (MTL) were grown in the presence of fluconazole. Derivatives were isolated, which had become homozygous for the resistance mutation and at the same time for the MTL. This loss of heterozygosity was accompanied by increased drug resistance. In general, strains which are homozygous for one of both MTL configurations (MTLa and MTLα) can switch to the opaque phenotype, which is the mating-competent form of the yeast, and mate with cells of the opposite MTL. In the following, MTLa and MTLα homozygous strains in the opaque phenotype were mated in all possible combinations. The resulting mating products with combined genetic material from both parents did not show an increased drug resistance. Selected products of each mating cross were passaged with stepwise increasing concentrations of fluconazole. The isolated progeny showed high levels of drug resistance and loss of wild-type alleles of resistance-associated genes. In conclusion, selective pressure caused by fluconazole exposure selects for resistance mutations and at the same time induces genomic rearrangements, resulting in mating competence. Therefore, in a clonal population, cells with individually acquired resistance mutations can mate with each other and generate mating products with combined genetic backgrounds. Selection can act on these mating products and highly drug-resistant und thus highly adapted derivatives can evolve as a result. In summary, the present study contributes to the current understanding of the evolution of antifungal drug resistance by elucidating the effect of resistance mutations on the fitness of the strains in the absence of the drug selection pressure and investigates how highly drug-resistant strains could evolve within a mammalian host.}, subject = {Evolution}, language = {en} } @phdthesis{daCruzGueerisoli2021, author = {da Cruz G{\"u}erisoli, Irene Maria}, title = {Investigating the murine meiotic telomere complex TERB1-TERB2-MAJIN: spatial organization and evolutionary history}, doi = {10.25972/OPUS-21056}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-210562}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2021}, abstract = {Einess der faszinierenden Merkmale der meiotischen Prophase I sind die hochkonservierten kr{\"a}ftigen Bewegungen homologer Chromosomen. Diese Bewegungen sind entscheidend f{\"u}r den Erfolg von Schl{\"u}sselereignissen wie die Ausrichtung, Paarung und Rekombination der homologen Chromosomen. Mehrere bisher untersuchte Organismen, darunter S{\"a}ugetiere, W{\"u}rmer, Hefen und Pflanzen, erreichen diese Bewegungen, indem sie die Chromosomenenden an spezialisierten Stellen in der Kernh{\"u}lle verankern. Diese Verankerung erfordert Telomer-Adapterproteine, die bisher in der Spalthefe und der Maus identifiziert wurden. Die meiosespezifischen Telomer-Adapterproteine der Maus, TERB1, TERB2 und MAJIN, sind an der Verankerung des ubiquit{\"a}ren Telomer-Shelterin-protein an den LINC-Komplex beteiligt, mit einem analogen Mechanismus, wie er die Spalthefe beschrieben wird. Obgleich die meiose-spezifischen TelomerAdapterproteine eine wesentliche Rolle spielen, ist der genaue Mechanismus der Verankerung der Telomere an die Kernh{\"u}lle sowie ihre evolution{\"a}re Geschichte bisher noch wenig verstanden. Das Hauptziel dieser Arbeit ist daher die Untersuchung der Organisation des meiosespezifischen TelomerAdapterkomplexes TERB1-TERB2-MAJIN der Maus und dessen Evolutionsgeschichte. Im ersten Teil dieser Arbeit wurde die Organisation des TERB1-TERB2-MAJIN Komplexes mittels hochaufl{\"o}sender Mikroskopie (SIM), an Mausspermatozyten untersucht, sowie die Lokalisation in Bezug auf TRF1 des Telomer-ShelterinKomplexes und die telomerische DNA analysiert. In den Stadien Zygot{\"a}n und Pachyt{\"a}n zeigten die Fluoreszenzsignale eine starke {\"U}berlappung der Verteilung der meiotischen Telomer-Komplex-Proteine, wobei die Organisation von TERB2 an den Chromosomenenden heterogener war als die von TERB1 und MAJIN. Außerdem konnte die TRF1-Lokalisation an den Enden der Lateralelemente (LEs) mit einer griffartigen Anordnung um die TERB1- und MAJIN-Signale im Zygot{\"a}n- und Pachyt{\"a}n-Stadium gezeigt werden. Interessanterweise erwies sich die telomerische DNA als lateral verteilt und teilweise {\"u}berlappend mit der zentralen Verteilung der meiotischen Telomer-Komplex-Proteine an den Enden der LEs. Die Kombination dieser Ergebnisse erlaubte die Beschreibung eines alternativen Modells der Verankerung der Telomer an die Kernh{\"u}lle w{\"a}hrend der meiotischen Prophase I. Der zweite Teil dieser Arbeit analysiert die Evolutionsgeschichte der Mausproteine von TERB1, TERB2 und MAJIN. Die fehlende {\"U}bereinstimmung zwischen den Meiose-spezifische Telomer-Adapteproteinen der Maus und der Spalthefe hat die Frage nach dem evolutionsbedingten Ursprung dieses spezifischen Komplexes aufgeworfen. Um vermeintliche Orthologen der Mausproteinevon TERB1, TERB2 und MAJIN {\"u}ber Metazoen hinweg zu identifizieren, wurden computergest{\"u}tzte Verfahren und phylogenetische Analysen durchgef{\"u}hrt. Dar{\"u}ber hinaus wurden Expressionsstudien implementiert, um ihre potenzielle Funktion w{\"a}hrend der Meiose zu testen. Die Analysen haben ergeben, dass der Meiose-spezifische Telomer-Komplex der Maus sehr alt ist, da er bereits in den Eumetazoen entstand, was auf einen einzigen Ursprung hindeutet. Das Fehlen jeglicher Homologen des meiosespezifischen Telomerkomplexes in Nematoden und die einigen wenigen in Arthropoden nachgewiesenen Kandidaten, deuten darauf hin, dass die Telomer-Adapterproteine in diesen Abstammungslinien verloren/ersetzt oder stark diversifiziert worden sind. Bemerkenswerterweise zeigten Proteindom{\"a}nen von TERB1, TERB2 und MAJIN, die an der Bildung des Komplexes sowie an der Interaktion mit dem Telomer-Shelterin-Protein und den LINC-Komplexen beteiligt sind, eine hohe Sequenz{\"a}hnlichkeit {\"u}ber alle Kladen hinweg. Abschließend lieferte die Genexpression im Nesseltier Hydra vulgaris den Beweis, dass der TERB1-TERB2-MAJIN-Komplex selektiv in der Keimbahn exprimiert wird, was auf die Konservierung meiotischer Funktionen {\"u}ber die gesamte Metazoen-Evolution hinweg hindeutet. Zusammenfassend bietet diese Arbeit bedeutende neue Erkenntnisse hinsichtlich des Meiose-spezifischen Telomer-Adapterkomplex, seines Mechanismus zur Verankerung der Telomer an die Kernh{\"u}lle und die Entschl{\"u}sselung seines Ursprungs in den Metazoen.}, language = {en} }